Ortho-Clinical Diagnostics, Inc. Company Profile

23:49 EDT 20th October 2014 | BioPortfolio

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers the high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit. Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, and automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care. For more information, visit www.orthoclinical.com.


News Articles [1308 Associated News Articles listed on BioPortfolio]

Ortho-Clinical Diagnostics Announces Executive Leadership Additions as It Becomes an Independent, Stand-Alone Company

Ortho-Clinical Diagnostics, Inc. unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group from Johnson & Johnson. In his first act as OCD...

Ortho-Clinical Diagnostics and Astute Medical to Develop Acute Kidney Injury Tests

Ortho-Clinical Diagnostics has entered into a strategic partnership with Astute Medical, under which OCD will become the exclusive commercial partner for the distribution of Astute’s NEPHROCHECK ® ...

Ortho-Clinical Diagnostics gets rights to AKI testing platform from Astute Medical

Diagnostics firm Astute Medical Inc. licensed Ortho-Clinical Diagnostics Inc. (OCD) exclusive rights to distribute its NephroCheck biomarker-based test and Astute140 meter in certain European markets ...

TRLPC: Ortho-Clinical Diagnostics details $2.525B buyout loan

NEW YORK, April 29 (Reuters) - Ortho-Clinical Diagnostics (OCD) outlined price guidance and terms on its $2.525 billion senior secured credit facility that funds, in part, the Johnson & Johnson Inc un...

J&J closes $4B sale of Ortho-Clinical Diagnostics business to Carlyle Group

US Johnson & Johnson (NYSE:JNJ), or J&J, said yesterday it had closed the sale of its unit Ortho-Clinical Diagnostics to asset management firm The Carlyle Group LP (NASDAQ:CG) for some...

Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group

NEW BRUNSWICK, N.J., June 30, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its Ortho-Clinical Diagnostics business to The Carlyl...

Astute, Ortho-Clinical Diagnostics deal

Robert Yates to be Named Chief Operating Officer of Ortho-Clinical Diagnostics, Inc. (OCD)

Newly Created Role to Begin Pending Close of Acquisition of OCD by The Carlyle Group Experienced Executive Has Proven Record of Delivering Significant Business Success in Diagnostics and Life Sc...

PubMed Articles [1613 Associated PubMed Articles listed on BioPortfolio]

Integrating molecular diagnostics into histopathology training: the Belfast model.

Molecular medicine is transforming modern clinical practice, from diagnostics to therapeutics. Discoveries in research are being incorporated into the clinical setting with increasing rapidity. This t...

Fungal diagnostics.

Early diagnosis of fungal infection is critical to effective treatment. There are many impediments to diagnosis such as a diminishing number of clinical mycologists, cost, time to result, and requirem...

Ruthenium-Catalyzed Cross-Dehydrogenative ortho-N-Carbazolation of Diarylamines: Versatile Access to Unsymmetrical Diamines.

The dehydrogenative C-N cross-coupling of unprotected, secondary anilines through ortho-N-carbazolation has been achieved using a Ru catalytic system with O2 as the terminal oxidant. The reactions pro...

Dihydrobiphenylenes through Ruthenium-Catalyzed 2+2+2 Cycloadditions of ortho-Alkenylarylacetylenes with Alkynes.

A new synthetic route to dihydrobiphenylenes has been developed. The process involves a mild Ru(II) -catalyzed [2+2+2] dimerization of ortho-alkenylarylacetylenes or its more versatile variant, the Ru...

Vitros 5600 Syphilis TPA Assay: Evaluation of an Automated Chemiluminescence Assay for Detection of Treponema pallidum Antibodies in a High Prevalence Setting.

The performance of the Syphilis TPA assay (Ortho-Clinical Diagnostics) on Vitros 5600 Integrated System was evaluated and demonstrated excellent results. Our data support the use of this assay for tes...

Clinical Trials [932 Associated Clinical Trials listed on BioPortfolio]

To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)

The objective of the study is to compare the oral contraceptive (OC) SH T00658ID over Ortho Tri-Cyclen Lo administered for 13 cycles to healthy female volunteers between 18 and 50 years of...

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

The purpose of this study is to assess the effect of BMS-790052 on the pharmacokinetics of Ortho Tri-Cyclen® in healthy female subjects.

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Topiramate (2 x 25 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Topamax®, Ortho-McNeil Neurologics, Inc.) in Fed, Healthy, Adult Subjects

- Objective: - Compare the bioequivalence of a test topiramate formulation (Torrent Pharmaceuticals Limited) to an equivalent oral dose of the commercially available ...

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

The purpose of this study is to administer a combined oral contraceptive (ethinyl estradiol and norgestimate) with the HIV treatment of atazanavir and ritonavir to healthy females in order...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Companies [2132 Associated Companies listed on BioPortfolio]

Ortho-Clinical Diagnostics, Inc.

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers the high-quality in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to mak...

Ortho Clinical Diagnostics

Ortho Women's Health & Urology(TM)

Ortho Women's Health & Urology(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a leader in the fields of women's health and urology, celebrating more than 75 years of partnering with w...

Ortho Kinematics

Ortho Kinematics is a privately held spine diagnostics enterprise committed to the idea that spine motion matters. The company is working with a group of leading clinicians, resea...

Ortho Biotech Incorporated

Ortho Biotech Inc. is a member of the Johnson & Johnson family of companies. As a company engaged in the business of innovative research, Ortho Biotech is pleased to share with professionals and patie...

More Information about "Ortho-Clinical Diagnostics, Inc." on BioPortfolio

We have published hundreds of Ortho-Clinical Diagnostics, Inc. news stories on BioPortfolio along with dozens of Ortho-Clinical Diagnostics, Inc. Clinical Trials and PubMed Articles about Ortho-Clinical Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ortho-Clinical Diagnostics, Inc. Companies in our database. You can also find out about relevant Ortho-Clinical Diagnostics, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record